No news is good news as far as the FDA is concerned. The President didn't offer any revelations last night, and we view this as a positive for all biotechnology companies.
Shares in the stock are up 94% in 2017. The YTD chart below shows today's spike and how its shares have performed this year.
At www.ValuEngine.com we show that the Medical sector 13.6% overvalued with the medical Instruments industry 2.0% undervalued. All 12 stocks in today’s table have complete ValuEngine data and
Bioanalytical Systems Inc is a contract research organization that provides drug discovery and development services and analytical instruments. The company operates in two business segments namely contract research services and research products. It generates maximum revenue from the contract research services segment. The contract research services segment provides screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing. Geographically, it derives a majority of revenue from the United States and also has a presence in Other North America; Pacific Rim; Europe, and Other Countries.
| Website: | www.basinc.com |
| Main Phone: | +1 765 463-4527 |
| Address: | 2701 Kent Avenue |
| State: | IN |
| City / Town: | West Lafayette |
| Country: | US |
| Postal Code: | 47906 |
| Exchange: | NSC |
| CEO: | Robert W. Leasure |
| Employees: | 421 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
No news is good news as far as the FDA is concerned. The President didn't offer any revelations last night, and we view this as a positive for all biotechnology companies.
Shares in the stock are up 94% in 2017. The YTD chart below shows today's spike and how its shares have performed this year.
At www.ValuEngine.com we show that the Medical sector 13.6% overvalued with the medical Instruments industry 2.0% undervalued. All 12 stocks in today’s table have complete ValuEngine data and
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 4 |
| Number of Buys | 0 | 4 |
| Number of Sells | 0 | 0 |
| Net Activity | 0 | 20000 |
| Last 10 Buys | Shares |
|---|---|
| Philip A. Downing | 1,000 |
| R. Matthew Neff | 1,000 |
| Gregory C. Davis | 1,000 |
| R. Matthew Neff | 1,000 |
| Connie Leigh Dougherty | 1,000 |
| Connie Leigh Dougherty | 1,000 |
| Connie Leigh Dougherty | 1,000 |
| Jacqueline M. Lemke | 1,000 |
| Jacqueline M. Lemke | 1,000 |
| Philip A. Downing | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| John P. Devine | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 2.15 | 2.15 | 2.15 | 2.15 |
| Low Target Price Estimate | 2.15 | 2.15 | 2.15 | 2.15 |
| Mean Target Price Estimate | 2.15 | 2.15 | 2.15 | 2.15 |
| Standard Deviation | 0 | 0 | 0 | 0 |
| Date of Most Recent Estimate | 05/29/13 | 05/29/13 | 05/29/13 | 05/29/13 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 10-Q | Quarterly report with a continuing view of a company's financial position | 27 | 2018-05-15 |
| 8-K | Report of unscheduled material events or corporate changes. | 11 | 2018-05-15 |
| 3 | Initial statement of beneficial ownership of securities | 1 | 2018-05-08 |
| 8-K | Report of unscheduled material events or corporate changes. | 13 | 2018-04-30 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-03-23 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-02-20 |
| 8-K | Report of unscheduled material events or corporate changes. | 10 | 2018-02-14 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 25 | 2018-02-14 |
| DEF 14A | Official notification to shareholders of matters to be brought to a vote (Proxy) | 40 | 2018-01-26 |
| 10-K | Annual report with a comprehensive overview of the company | 81 | 2017-12-22 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 0 | 0 | 1 | 1 |
© 2021 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
